Scorpius BioManufacturing is a boutique US-based CDMO offering mammalian clinical manufacturing services including cell culture process development, analytical development, and cGMP production for antibodies, vaccines, and therapeutic proteins.
At Scorpius we prioritize small programs and commit to giving your biologic the personalized attention and systematic flexibility that is deserves. We have dedicated ~5,400 sq. ft. of our facility to mammalian manufacturing in nine cGMP-compliant controlled cleanrooms with dedicated air handling units designed for maximal segregation. Each of these cleanroom areas is designed for maximum flexibility in mind, with much of the equipment on wheels for easily customized room formats. We offer cell culture development and manufacturing using CHO and HEK-293 cell expression systems.
US-Based Mammalian Cell Culture Services
As is the case with the rest of our facility, the cleanrooms use American-made equipment and consumables, with many supplied mechanicals made on-site. Every modular cleanroom area in Scorpius' facility includes water for injection (WFI) drops as needed along with multiple electrical and process gas drops for mammalian cell culture incubators, bioreactors, cell harvesting systems, downstream filtration systems, and purification systems.
Our Mammalian CDMO Capabilities:
![]()
|
![]()
|
![]()
|
![]()
|
Therapeutic Proteins |
Antibody Production |
Bioanalytical Services | Vaccine Manufacturing |
The controlled areas are designed for unidirectional flow of personnel, raw materials, intermediates, product, and waste. The material finishes used on the cleanroom walls, floors and ceilings were selected for ease of cleaning and are suited to cGMP-compliant biomanufacturing.
Scorpius BioManufacturing's cGMP-compliant mammalian cell culture facilities are equipped with bioreactors with capacities of 50, 200, 500 L, including the Pall Allegro™ STR single-use family of stirred tank bioreactors.